Articles and Case Studies

Medication error: hydromorphone

01 Apr 2007

Dr Sara Bird

by Dr Sara Bird

Consider the case of the 35 year-old patient who attended the regional hospital’s Emergency Department (ED) complaining of a severe episode of renal colic.

Case history

The patient had had a number of previous renal stones and had undergone ureteric stenting in the past. The patient informed the doctor that he was allergic to pethidine, morphine and various other analgesics. He specifically requested hydromorphone for the pain. The patient reported that this had been the most effective medication in the past. The ED doctor had not previously used hydromorphone but she was advised by the nursing staff that there were five vials of hydormorphone in the ward. While the doctor was seeing another patient in the ED, one of the nursing staff asked her to chart the hydromorphone so that the patient could be transferred to the day stay ward for observation. The doctor charted “hydromorphine 10mg” believing that it was the same as other morphine derivatives. Fortunately, the patient did not suffer any long term adverse sequelae from the excessive dose of hydromorphone.


Hydromorphone (Dilaudid) is an opioid analgesic used for the management of moderate to severe pain. Over the years, a number of incidents have been reported involving the prescription of hydromorphone. While in many of the cases the patients suffered no residual complications related to the medication, in some cases the incidents have resulted in patient deaths. Most of the cases have involved either wrong dosage or over-prescribing of opioid analgesia. Hydromorphone is approximately eight times more potent than morphine. As always, if prescribing a medication with which you are unfamiliar, check the relevant prescribing information before charting the medication.

Clinical, Emergency Medicine


My Career Journey with Dr Nick Coatsworth

Dr Nick Coatsworth is an expert in health policy, public administration and a practising infectious diseases physician. He held a national role in the Australian response to COVID-19 as Deputy Chief Medical Officer of Australia, becoming one of the most recognised medical spokespeople during the pandemic. Nick engaged the Australian community through a variety of media platforms most notably as the spearhead of the national COVID-19 vaccination campaign. Dr Micheal Gannon, Obstetrician & Gynaecologist, sits down with Dr Nick Coatsworth to discuss Nick's medical career journey, and what insights and advice he has for junior doctors. MDA National would like to acknowledge the contributions of MDA National staff, Members, friends and colleagues in the production of the podcast and note that this work is copyright. Apart from any use permitted under applicable copyright law, you may not reproduce the content of this podcast without the permission of MDA National. This podcast contains generic information only, is intended to stimulate thought and discussion, and doesn’t account for requirements of any particular individual. The content may contain opinions which are not necessarily those of MDA National. We recommend that you always contact your indemnity provider when you require specific advice in relation to your insurance policy or medico-legal matters. MDA National Members need to contact us for specific medico-legal advice on freecall 1800 011 255 or email We may also refer you to other professional services.


09 Jun 2022

Career complications and contending with uncertainty

Among the many challenges of the COVID-19 pandemic for junior doctors is how to respond to medical training impacts and career uncertainty. In this podcast, Dr Caroline Elton (a psychologist who specialises in helping doctors)and Dr Benjamin Veness (a Psychiatry registrar) share advice for coping with medical training and career delays, disruptions and unknowns.


10 Aug 2020